Microba Life Sciences Ltd
ASX:MAP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Miyazaki Bank Ltd
TSE:8393
|
JP |
|
Mycelx Technologies Corp
LSE:MYX
|
US |
|
Hainan Airlines Holding Co Ltd
SSE:600221
|
CN |
Microba Life Sciences Ltd
Other Current Assets
Microba Life Sciences Ltd
Other Current Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Current Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
M
|
Microba Life Sciences Ltd
ASX:MAP
|
Other Current Assets
AU$2.1m
|
CAGR 3-Years
-28%
|
CAGR 5-Years
53%
|
CAGR 10-Years
N/A
|
|
|
Sonic Healthcare Ltd
ASX:SHL
|
Other Current Assets
AU$156.9m
|
CAGR 3-Years
13%
|
CAGR 5-Years
18%
|
CAGR 10-Years
11%
|
|
|
Integral Diagnostics Ltd
ASX:IDX
|
Other Current Assets
AU$18.8m
|
CAGR 3-Years
25%
|
CAGR 5-Years
28%
|
CAGR 10-Years
N/A
|
|
|
Australian Clinical Labs Ltd
ASX:ACL
|
Other Current Assets
AU$9.5m
|
CAGR 3-Years
32%
|
CAGR 5-Years
26%
|
CAGR 10-Years
N/A
|
|
|
Apiam Animal Health Ltd
ASX:AHX
|
Other Current Assets
AU$1.8m
|
CAGR 3-Years
3%
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
|
|
H
|
Healius Ltd
ASX:HLS
|
Other Current Assets
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Microba Life Sciences Ltd
Glance View
Microba Life Sciences is a precision microbiome science company powering medical innovation to transform human health. The company is headquartered in Brisbane, Queensland. The company went IPO on 2022-04-05. The firm specializes in the analysis of gut microbiome and promotes development in pathology services, therapeutics and diagnostics based on the microbiome. The firm's flagship product is the Microba Insight, a sampling kit that allows the public to analyze personal gut microbiome. Its discovery platform uses human data and informatic approaches to connect microbial genotype to human phenotype. The company also offers support solutions to researchers.
See Also
What is Microba Life Sciences Ltd's Other Current Assets?
Other Current Assets
2.1m
AUD
Based on the financial report for Jun 30, 2025, Microba Life Sciences Ltd's Other Current Assets amounts to 2.1m AUD.
What is Microba Life Sciences Ltd's Other Current Assets growth rate?
Other Current Assets CAGR 5Y
53%
Over the last year, the Other Current Assets growth was 156%. The average annual Other Current Assets growth rates for Microba Life Sciences Ltd have been -28% over the past three years , 53% over the past five years .
